Novel ALK inhibitors in clinical use and development
Senolytic drugs: from discovery to translation Kirkland JL, Tchkonia T Journal of Internal Medicine (2020) This comprehensive review from the Mayo Clinic's leading senescence researchers places FOXO4-DRI within the broader context of senolytic drug development and clinical translation
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
Fat loss was measured primarily through weight, BMI, and waist circumference changes
Pay attention to your regularity, your energy levels, and how your clothes fit
Whether the research focus is metabolic, body composition, or exploratory, the core principles remain: Start low: 0.5 to 1 mg is a safe starting dose